Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy
Authors:
- Elina HemminkiEHElina Hemminki
- Sirpa-Liisa HoviSHSirpa-Liisa Hovi
- Piret VeerusPVPiret Veerus
- Tiina SevónTSTiina Sevón
- Risto TuimalaRTRisto Tuimala
- Mati RahuMRMati Rahu
- Matti HakamaMHMatti Hakama
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 57 (12) , 1237-1243
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Finland
- Opetus- ja Kulttuuriministeriö
This publication has 20 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- What are the main methodological problems in the estimation of placebo effects?Journal of Clinical Epidemiology, 2002
- Determinants of long-term hormone replacement therapy and reasons for early discontinuationObstetrics & Gynecology, 2000
- Why use placebos in clinical trials? A narrative review of the methodological literatureJournal of Clinical Epidemiology, 2000
- Evaluation of specific and non-specific effects in homeopathy: feasibility study for a randomised trialBritish Homoeopathic journal, 2000
- Important Factors for Use of Hormone Replacement TherapyMenopause, 2000
- Barriers to Participation in Randomised Controlled TrialsJournal of Clinical Epidemiology, 1999
- Patient sociodemographic characteristics as predictors of satisfaction with medical care: A meta-analysisSocial Science & Medicine, 1990
- Meta-analysis of satisfaction with medical care: Description of research domain and analysis of overall satisfaction levelsSocial Science & Medicine, 1988
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979